MedPath

Benefits of Using Intrathecal Buprenorphine

Not Applicable
Conditions
Post operative pain managment and adverse effect of intratechal buprenorphine.
Reactions and Intoxications From Maternal Opiates and Tranquillizers Administered During Labour and Delivery
Registration Number
IRCT2013022112552N1
Lead Sponsor
Babol Univesity of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
400
Inclusion Criteria

Inclusion Criteria: All pregnant women candidate for elective cesarean section, in ASA class I (American Society of Anesthesiology) aged 17-41 Years.

Exclusion Criteria

Maternal or fetal contraindication for spinal anesthesia; Severe fetus distress; Emergency Cesarean; Addiction, Drug or OTC abuse, Using Anti-epileptic drugs, Blood pressure more than 140/90 mmHg, Gestational diabetes,Psychiatric problems; Uncontrolled co-existent internal disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain free period after operation. Timepoint: Pain assessment before, during and after surgery with Visual Analogue Score (VAS). Method of measurement: Visual Analogue Scale (VAS).
Secondary Outcome Measures
NameTimeMethod
Post Operative Nausea. Timepoint: Before anesthesia, 5 Min interval after spinal anesthesia, then every 6 hours in the ward. Method of measurement: Questionnaire.;Post Operative Vomitting. Timepoint: Before anesthesia, 5 Min interval after spinal anesthesia, then every 6 hours in the ward. Method of measurement: Questionnaire.;Hemodynamic Factors. Timepoint: Before anesthesia, 5 Min interval after spinal anesthesia, then every 6 hours in the ward. Method of measurement: Standard Manometer, Standard Therometer.
© Copyright 2025. All Rights Reserved by MedPath